A single center experience with romiplostim for the management of chemotherapy-induced thrombocytopenia
Author:
Affiliation:
1. Department of Pharmacy; Dana-Farber Cancer Institute; Boston Massachusetts
2. Division of Hematology; Brigham and Women's Hospital and Harvard Medical School; Boston Massachusetts
Publisher
Wiley
Subject
Hematology
Reference6 articles.
1. 9248 Safety of romiplostim for treatment of chemotherapy-induced thrombocytopenia (CIT) in patients with advanced non-small cell lung cancer (NSCLC);Natale;Eur J Cancer Suppl.,2009
2. Romiplostim for management of chemotherapy-induced thrombocytopenia;Parameswaran;Support Care Cancer.,2014
3. Randomized, double-blind, placebo-controlled, dose and schedule-finding study of AMG 531 in chemotherapy-induced thrombocytopenia (CIT): results of a phase I/II study;Vadhan-Raj;Blood.,2010
4. Romiplostim for treatment and prevention of chemotherapy-associated thrombocytopenia;Al-Samkari;Blood.,2016
5. Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand;Wang;Clin Pharmacol Ther.,2004
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel Perspectives on Thrombopoietin Receptor Agonists Applications;Hämostaseologie;2024-03-18
2. Hetrombopag for the management of chemotherapy-induced thrombocytopenia in patients with advanced solid tumors: a multicenter, randomized, double-blind, placebo-controlled, phase II study;Therapeutic Advances in Medical Oncology;2024-01
3. Disparities in the consensus for treatment of chemotherapy-induced thrombocytopenia;ecancermedicalscience;2023-11-13
4. Effects of thrombopoietin pre-treatment on peri-liver transplantation thrombocytopenia in a mouse model of cirrhosis with hypersplenism;World Journal of Gastrointestinal Surgery;2023-10-27
5. Antithrombotic and hemostatic stewardship: Evaluation of romiplostim for treatment of thrombocytopenia at a large academic medical center;Journal of Oncology Pharmacy Practice;2023-05-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3